{"id":"W4400650260","doi":"10.1001/jamainternmed.2024.2559","title":"Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany","year":2024,"lang":"en","type":"article","venue":"JAMA Internal Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Weight loss; Glucagon-like peptide-1; Exenatide; Glucagon-like peptide 1 receptor; Internal medicine; Obesity; Endocrinology; Diabetes mellitus; Receptor; Agonist; Type 2 diabetes","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006519299,0.0001712115,0.0002395534,0.003059535,0.0008510659,0.002093371,0.0003885618,0.0004511689,0.004988495],"category_scores_gemma":[0.002967458,0.0001326007,0.0006272123,0.004695314,0.0006612958,0.0007053,0.0009222659,0.0006574735,0.0001840132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01311685,"about_ca_system_score_gemma":0.01394306,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.905255,"about_ca_topic_score_gemma":0.9477189,"domain_scores_codex":[0.9982275,0.0001657571,0.00008484984,0.00009672346,0.0004651501,0.0009600074],"domain_scores_gemma":[0.9981026,0.0001978017,0.0004287517,0.00004766421,0.0006541518,0.000569112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001359713,0.0001568571,0.7614221,0.0003758477,0.0008020386,0.0010571,0.001381617,0.003945002,0.0007248559,0.03642097,0.05220901,0.1401449],"study_design_scores_gemma":[0.00009025153,0.00009298039,0.9602263,0.0003435086,0.0001876114,0.0003649764,0.002937689,0.0008517617,0.0003042688,0.000850671,0.03370449,0.00004542856],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8425687,0.02187254,0.0004144201,0.02017003,0.0003022734,0.00006530267,0.01563109,0.00006500293,0.0989107],"genre_scores_gemma":[0.9869652,0.005546191,0.0002274185,0.001593818,0.00007055794,0.00001755164,0.002568455,0.00001431963,0.002996426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09474498,"threshold_uncertainty_score":0.1906059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009186637104439958,"score_gpt":0.2770989490329122,"score_spread":0.2679123119284723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}